Perspective Therapeutics, Inc.

Perspective Therapeutics, Inc. develops, manufactures, and markets isotope-based medical products and devices for cancer treatment. Its flagship product, CS-1 Cesium-131 brachytherapy seeds, is used for various cancer types including prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. The company generates revenue by selling these products to facilities and physician practices that utilize surgical facilities for cancer treatment.